By Seun Ibiyemi
The National Agency for Food and Drug Administration and Control (NAFDAC) has reiterated its commitment to strengthening Nigeria’s pharmaceutical sector through international collaboration, as it hosted the High Commissioner of Bangladesh to Nigeria, Miah Md. Mainul Kabir, on a courtesy visit in Abuja.
Speaking during the meeting, NAFDAC Director-General, Mojisola Adeyeye, highlighted the agency’s readiness to partner with Bangladesh in advancing pharmaceutical development, enhancing regulatory systems, and expanding trade and investment opportunities.
Adeyeye emphasised NAFDAC’s mandate to ensure the availability of safe, quality, and efficacious medicines through robust regulatory frameworks and effective post-market surveillance.
She noted that Nigeria’s pharmaceutical sector has recorded significant growth, driven by reforms and strengthened regulatory oversight, including the agency’s attainment of the World Health Organization Maturity Level 3 status.
The NAFDAC boss also underscored the importance of increased investment in local drug manufacturing, particularly in vaccines and biologics, as part of efforts to boost domestic capacity and reduce reliance on imports.
Read also:NERC, State regulators launch FONER to strengthen power sector oversight
According to her, collaboration with Bangladesh presents an opportunity for technological exchange, knowledge sharing, and improved access to high-quality medicines for both countries.
Earlier, Kabir expressed Bangladesh’s interest in deepening cooperation with NAFDAC, noting that such a partnership would enhance pharmaceutical trade and deliver mutual benefits in healthcare delivery.
The engagement reflects NAFDAC’s broader strategy to build global partnerships that strengthen regulatory standards and support the growth of Nigeria’s healthcare and pharmaceutical industries.
